0001562180-19-003124.txt : 20190528 0001562180-19-003124.hdr.sgml : 20190528 20190528160452 ACCESSION NUMBER: 0001562180-19-003124 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190523 FILED AS OF DATE: 20190528 DATE AS OF CHANGE: 20190528 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sandor Victor CENTRAL INDEX KEY: 0001620368 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16633 FILM NUMBER: 19857691 MAIL ADDRESS: STREET 1: C/O ARRAY BIOPHARMA INC. STREET 2: 3200 WALNUT STREET CITY: BOULDER STATE: CO ZIP: 80301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARRAY BIOPHARMA INC CENTRAL INDEX KEY: 0001100412 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841460811 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 3200 WALNUT STREET CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 3033816600 MAIL ADDRESS: STREET 1: 3200 WALNUT STREET CITY: BOULDER STATE: CO ZIP: 80301 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2019-05-23 false 0001100412 ARRAY BIOPHARMA INC ARRY 0001620368 Sandor Victor C/O ARRAY BIOPHARMA INC. 3200 WALNUT STREET BOULDER CO 80301 false true false false Chief Medical Officer Common Stock 2019-05-23 4 M false 40634.00 3.65 A 278326.00 D Common Stock 2019-05-23 4 S false 40634.00 26.5011 D 237692.00 D Common Stock 2019-05-28 4 M false 46766.00 3.65 A 284458.00 D Common Stock 2019-05-28 4 S false 74915.00 27.003 D 209543.00 D Stock Option (Right to Buy) 3.65 2019-05-23 4 M false 40634.00 0.00 D 2024-09-22 Common Stock 40634.00 98628.00 D Stock Options (Right to buy) 3.65 2019-05-28 4 M false 46766.00 0.00 D 2024-09-22 Common Stock 46766.00 51862.00 D These trades were made pursuant to a Rule 10b5-1 trading plan. The price reported for these shares is the weighted average sale price of transactions made at prices from $26.50 to $26.51. Details of actual prices for shares sold are available from the Issuer upon request. The price reported for these shares is the weighted average sale price of transactions made at prices from $26.75 to $27.10. Details of actual prices for shares sold are available from the Issuer upon request. The option vested in four equal annual installments beginning on September 22, 2015. Jason Haddock, attorney-in-fact for Victor Sandor 2019-05-28